GE HealthCare Techs Analyst Price Targets

Wall Street analyst price targets and consensus rating for GE HealthCare Techs (GEHC).

Price Target Range — 13 Quarters

Analyst Consensus — 19 Analysts

12Buy

7Hold

Consensus RatingBuy# Analysts19Avg. Consensus PT$84Upside to Avg. PT+9.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 29, 2026	JP Morgan	Robbie Marcus	PT Raise	Neutral	$70→$80
Oct 29, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$71→$79
Oct 29, 2026	RBC Capital	Kendall Au	PT Raise	Outperform	$80→$90
Oct 29, 2026	Barclays	Christopher Pasquale	PT Raise	Overweight	$85→$95
Oct 28, 2026	BTIG	Ryan Zimmerman	PT Raise	Buy	$75→$83
Oct 12, 2026	BTIG	Ryan Zimmerman	PT Cut	Buy	$79→$75
Oct 7, 2026	Barclays	Christopher Pasquale	Initiate	Overweight	$85
Oct 5, 2026	Citigroup	Joanne Wuensch	PT Cut	Neutral	$75→$71
Oct 5, 2026	Needham	David Saxon	Maintained	Buy	$93
Sep 22, 2026	Needham	David Saxon	Initiate	Buy	$93
Sep 17, 2026	BTIG	Ryan Zimmerman	Maintained	Buy	$79
Aug 19, 2026	BTIG	Ryan Zimmerman	Maintained	Buy	$79
Jul 31, 2026	UBS	Graham Doyle	PT Raise	Neutral	$67→$73
Jul 30, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$69→$75
Jul 30, 2026	Evercore ISI Group	Vijay Kumar	PT Raise	Outperform	$80→$84
Jul 30, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$75→$85
Jul 29, 2026	BTIG	Ryan Zimmerman	PT Raise	Buy	$75→$79
Jul 17, 2026	Hovde Group	—	Initiate	Market Perform	$14
Jul 16, 2026	UBS	Graham Doyle	PT Cut	Neutral	$69→$67
Jul 9, 2026	BMO Capital	—	Initiate	Market Perform	$70

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on GE HealthCare Techs, Raises Price Target to $80

JP Morgan analyst Robbie Marcus maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and raises the price target from $70 to $80.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on GE HealthCare Techs, Raises Price Target to $79

Citigroup analyst Joanne Wuensch maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and raises the price target from $71 to $79.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on GE HealthCare Techs, Raises Price Target to $90

RBC Capital analyst Kendall Au maintains GE HealthCare Techs (NASDAQ:GEHC) with a Outperform and raises the price target from $80 to $90.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on GE HealthCare Techs, Raises Price Target to $95

Barclays analyst Christopher Pasquale maintains GE HealthCare Techs (NASDAQ:GEHC) with a Overweight and raises the price target from $85 to $95.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on GE HealthCare Techs, Raises Price Target to $83

BTIG analyst Ryan Zimmerman maintains GE HealthCare Techs (NASDAQ:GEHC) with a Buy and raises the price target from $75 to $83.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on GE HealthCare Techs, Lowers Price Target to $75

BTIG analyst Ryan Zimmerman maintains GE HealthCare Techs (NASDAQ:GEHC) with a Buy and lowers the price target from $79 to $75.

Benzinga Newsdesk

GE HealthCare Technologies Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

GE HealthCare Techs Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on GE HealthCare Techs, Raises Price Target to $80

PRO
Citigroup Maintains Neutral on GE HealthCare Techs, Raises Price Target to $79

PRO
RBC Capital Maintains Outperform on GE HealthCare Techs, Raises Price Target to $90

PRO
Barclays Maintains Overweight on GE HealthCare Techs, Raises Price Target to $95

PRO
BTIG Maintains Buy on GE HealthCare Techs, Raises Price Target to $83

PRO
BTIG Maintains Buy on GE HealthCare Techs, Lowers Price Target to $75

People Also Watch

People Also Watch

GE HealthCare Technologies Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

GE HealthCare Techs Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROJP Morgan Maintains Neutral on GE HealthCare Techs, Raises Price Target to $80

PROCitigroup Maintains Neutral on GE HealthCare Techs, Raises Price Target to $79

PRORBC Capital Maintains Outperform on GE HealthCare Techs, Raises Price Target to $90

PROBarclays Maintains Overweight on GE HealthCare Techs, Raises Price Target to $95

PROBTIG Maintains Buy on GE HealthCare Techs, Raises Price Target to $83

PROBTIG Maintains Buy on GE HealthCare Techs, Lowers Price Target to $75

People Also Watch

People Also Watch

PRO
JP Morgan Maintains Neutral on GE HealthCare Techs, Raises Price Target to $80

PRO
Citigroup Maintains Neutral on GE HealthCare Techs, Raises Price Target to $79

PRO
RBC Capital Maintains Outperform on GE HealthCare Techs, Raises Price Target to $90

PRO
Barclays Maintains Overweight on GE HealthCare Techs, Raises Price Target to $95

PRO
BTIG Maintains Buy on GE HealthCare Techs, Raises Price Target to $83

PRO
BTIG Maintains Buy on GE HealthCare Techs, Lowers Price Target to $75